The Department of Health and Human Services Centers for Disease Control and Prevention in Pittsburgh awarded Roche Diagnostics Corporation a $53,105 purchase order contract to provide MAGNA PURE24 products. The contract has a firm fixed price and period of performance from September 19, 2023 through October 31, 2023. Place of performance will be Roche's facility in Castleton, Indiana. No subcontractors or set aside designations were identified. The CDC likely requires the MAGNA PURE24...
Roche Diagnostics Corporation was awarded a firm fixed price purchase order by the Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh. The award, valued at two hundred thirty-seven thousand seven hundred forty-one dollars and sixty cents ($237,741.60), is for the product "MAGNA PURE 96" and has a completion date of October 15, 2020. The place of performance is Castleton, Indiana. No set-aside designation was used for this contract. Roche...
The Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh awarded a $165,500 firm fixed price purchase order to Roche Diagnostics Corporation. Under this contract, Roche will provide ROCHE COBAS 5800 laboratory equipment to the CDC in Castleton, Indiana by mid-November 2023. The CDC is a leading public health agency, and this equipment will likely support its efforts to advance health equity and combat infectious diseases through laboratory testing and...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm-fixed-price purchase order to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for the delivery of MAGNA PURE 96 INSTRUMENTS. The contract, which has a potential value of $180,000.00, does not have a set-aside designation and has an anticipated completion date of April 15, 2022. Roche Diagnostics, a foreign-owned, for-profit manufacturer of in vitro diagnostics,...
The Centers for Disease Control and Prevention (CDC) awarded a $93,496 purchase order to Roche Diagnostics Corporation for the delivery of Roche COBAS C6800/AMPLIPREP/CAPTAQ systems. This firm fixed price contract will provide the CDC's Pittsburgh location with laboratory equipment and supplies to support its disease testing and prevention efforts. Roche will deliver the requested products to the CDC site in Castleton, Indiana by October 25, 2023. No subcontractors or set aside designations were...
Roche Diagnostics Corporation was awarded a firm fixed price purchase order by the Centers for Disease Control and Prevention Pittsburgh on behalf of the Department of Health and Human Services. The $6,760 contract is for MAGNAPURE 24 service to be completed by March 1, 2025 with performance in Atlanta, GA. No set-aside designation was used for this award. The purchase order is likely placed against an existing Roche Diagnostics GSA Schedule, Indefinite Delivery Contract, or Blanket Purchase...
This firm fixed price purchase order for $77,096.13 was awarded on June 4, 2022 by the Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for reagents. The contract does not have a set-aside designation. Roche Diagnostics Corp will provide the reagents to the CDC by September 30, 2022. Roche Diagnostics holds multiple General Services Administration Schedule contracts and...
This is a firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation, a manufacturer of in vitro diagnostics, laboratory instruments, and associated products and services. The $113,563 contract provides ICF laboratory equipment and maintenance for the CDC's Pittsburgh location. This award is not designated as a set-aside. Roche Diagnostics has received numerous federal contract awards from agencies including the Department...
This firm fixed-price purchase order contract was awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract is for the MAGNA PURE 96 INSTRUMENT IVD, with a ceiling value of $90,000.00 and a completion date of July 15, 2017. Roche Diagnostics has received numerous federal contract awards, including through its...
This is a $97,000.00 firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract is for the acquisition of MAGNA PURE EQUIPMENT and does not have a set-aside designation. Roche Diagnostics has received multiple prime contract and subcontract awards from various federal agencies to provide...